lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Medcast news and blog

Anthony is having frequent exacerbations of his COPD….why is his physician considering a GLP1 agonist?

Anthony is a retired engineer, who is compliant with his COPD and diabetes management but has been struggling with frequent exacerbations of his COPD.

READ ON
Clinical Opal #11 - SGLT2i-related DKA
Clinical Opal #11 - SGLT2i-related DKA
Dr Simon Morgan

Terese is a 64-year-old retired teacher who has a 12 year history of type 2 diabetes. She also has hypertension...

Diabetes in General Practice
Diabetes in General Practice
Dr Simon Morgan

It's one thing for a medication to demonstrate an effect in the narrowly selected, hermetically sealed and artificially monitored setting of a clinical trial.

Cardiovascular outcome data in type 2 diabetes, does it really matter to me and my patients?
Cardiovascular outcome data in type 2 diabetes, does it really matter to me and my patients?
Dr Sarah Davies

So, we’ve heard about all this recent “exciting” cardiovascular outcome data in type 2 diabetes, but is there a real tangible benefit to our own patients outside of a clinical trial setting? How should we be incorporating it into our own clinical practice?

Mental Health and Diabetes
Mental Health and Diabetes
Dr Vered Gordon

The emotional health of people living with diabetes has been receiving greater attention as we become increasingly aware of the often-unrecognised psychological distress experienced by the approximately 1.2 million people in Australia living with diabetes.